PERFECTHA® DERM Lidocaine

Key Uses of Perfectha Derm Lidocaine

• Enhancement and balancing of lip proportions while refining their overall shape and volume
• Significant hydration and volume restoration in areas where natural hyaluronic acid has depleted
• Treatment of aesthetic concerns resulting from ageing, significant weight changes, or medical conditions including morphological asymmetry, scarring, and facial lipoatrophy
• Smoothing and correction of moderate facial lines, wrinkles, and skin depression

Manufacturing Information for Perfectha Derm Lidocaine

Perfectha Derm Lidocaine is produced by ObvieLine Laboratories, a French pharmaceutical company operating as part of the UK-based Sinclair Pharma organisation.

Expected Benefits and Results of the Treatment

• The specially formulated cross-linked hyaluronic acid works to enhance skin volume and hydration, naturally integrating with body tissues over time
• The inclusion of lidocaine provides effective pain management during the injection process
• Due to its biocompatible composition, this filler minimizes the risk of adverse reactions and sensitivity issues
• The product excels in precise lip augmentation and addresses various aesthetic concerns, including those caused by significant weight changes or medical conditions
• Patients appreciate the quick treatment sessions and minimal recovery period, making this an excellent option for long-lasting aesthetic enhancement

Perfectha Derm Lidocaine Key Ingredients and Device Features

• Cross-linked hyaluronic acid at 20 mg/ml concentration
• Lidocaine hydrochloride at 3 mg/ml concentration
• Sodium Chloride
• Sodium dihydrogen phosphate
• Disodium Phosphate
• Water for Injections
• Density of 90,000 gel particles per ml
• Steam-sterilized syringe contents

Included Items or Accessories

• A single pre-filled syringe containing 1ml of product
• Two 30G 1/2″ needles
• Detailed package insert
• Two traceability labels for record-keeping

Administration Method for Perfectha Derm Lidocaine

The administration of this dermal filler must be performed exclusively by qualified medical professionals. Before treatment, practitioners should discuss aesthetic goals with patients and review their complete medical history. 

The treatment area must be thoroughly cleaned and disinfected. The filler should be injected into the superficial subcutaneous layer of the skin. Following injection, gentle massage of the treated area ensures even distribution of the gel. Practitioners should monitor for immediate side effects and provide detailed recovery instructions to patients.

Guidelines for Proper Aftercare

• Patients should avoid consuming alcohol and blood-thinning substances after treatment.
• Makeup application and harsh skincare products should be avoided for several days post-procedure. 
• Physical activities that cause excessive sweating should be limited to prevent skin irritation. 
• Direct sunlight and UV exposure should be avoided during the initial recovery period. 
• Any swelling can be managed with ice or cold compress application. 
• Patients should temporarily avoid pools, saunas, beaches, and public baths during the healing process.

Duration of Perfectha Derm Lidocaine Effects

Patients can expect the rejuvenating benefits of Perfectha Derm Lidocaine to last up to 12 months for facial and hand treatments. For lip enhancement procedures, results typically maintain their appearance for up to 6 months.

Potential Risks and Side Effects

As with any injectable procedure, patients may experience common mild side effects including pain, redness, tenderness, hematoma, bruising, and swelling at the injection sites. More serious adverse reactions requiring immediate medical attention may include allergic responses, infections, filler migration, or the formation of lumps beneath the skin.

Perfectha Derm Lidocaine Treatment Contraindications

Treatment is not suitable for the following individuals:

• Those with active facial or lip infections

• Individuals with known allergies to hyaluronic acid or lidocaine

• Persons under 18 years of age

• Pregnant or breastfeeding women

• Patients with autoimmune conditions

• Individuals who have recently undergone medical procedures or treatments and are still in recovery